A detailed history of Rothschild Investment LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 75 shares of CORT stock, worth $3,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75
Previous 35 114.29%
Holding current value
$3,935
Previous $1.14 Million 205.28%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$29.51 - $46.26 $1,180 - $1,850
40 Added 114.29%
75 $3.47 Million
Q2 2024

Jul 30, 2024

BUY
$22.21 - $34.48 $777 - $1,206
35 New
35 $1.14 Million
Q1 2024

Jul 31, 2024

SELL
$21.1 - $27.46 $633 - $823
-30 Reduced 85.71%
5 $126,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.62B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.